AbClon Inc (174900) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.055x

Based on the latest financial reports, AbClon Inc (174900) has a cash flow conversion efficiency ratio of -0.055x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.19 Billion ≈ $-2.16 Million USD) by net assets (₩58.28 Billion ≈ $39.49 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is AbClon Inc's balance sheet to measure how much of total assets are equity-financed.

AbClon Inc - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how AbClon Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of AbClon Inc to evaluate the quality of earnings relative to operating cash generation.

AbClon Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of AbClon Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
WCM Beteiligungs- und Grundbesitz-AG F:WCMK	-0.005x
Amarin Corporation PLC NASDAQ:AMRN	0.014x
Jiangsu Sainty Corp Ltd SHG:600287	-0.022x
Career Technology MFG Co Ltd TW:6153	-0.028x
Fujian Cement Inc SHG:600802	-0.135x
Shenzhen Capol International & Associates Co Ltd SHE:002949	0.064x
Suzhou Institute of Building Science Group Co Ltd SHG:603183	-0.004x
Hefei Jingsong Intelligent Technology Co. Ltd. A SHG:688251	N/A

Annual Cash Flow Conversion Efficiency for AbClon Inc (2015–2025)

The table below shows the annual cash flow conversion efficiency of AbClon Inc from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of AbClon Inc.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩60.44 Billion ≈ $40.96 Million	₩-13.83 Billion ≈ $-9.37 Million	-0.229x	+53.26%
2024-12-31	₩29.41 Billion ≈ $19.93 Million	₩-14.39 Billion ≈ $-9.75 Million	-0.490x	-40.56%
2023-12-31	₩27.23 Billion ≈ $18.46 Million	₩-9.48 Billion ≈ $-6.43 Million	-0.348x	-70.15%
2022-12-31	₩36.60 Billion ≈ $24.81 Million	₩-7.49 Billion ≈ $-5.08 Million	-0.205x	+54.15%
2021-12-31	₩19.36 Billion ≈ $13.12 Million	₩-8.64 Billion ≈ $-5.86 Million	-0.446x	-131.82%
2020-12-31	₩29.33 Billion ≈ $19.88 Million	₩-5.65 Billion ≈ $-3.83 Million	-0.193x	-1414.49%
2019-12-31	₩35.38 Billion ≈ $23.98 Million	₩-449.88 Million ≈ $-304.88K	-0.013x	-106.40%
2018-12-31	₩18.70 Billion ≈ $12.67 Million	₩3.71 Billion ≈ $2.52 Million	0.199x	+409.96%
2017-12-31	₩17.39 Billion ≈ $11.79 Million	₩-1.11 Billion ≈ $-755.45K	-0.064x	-274.68%
2016-12-31	₩11.98 Billion ≈ $8.12 Million	₩-204.92 Million ≈ $-138.87K	-0.017x	+89.66%
2015-12-31	₩13.31 Billion ≈ $9.02 Million	₩-2.20 Billion ≈ $-1.49 Million	-0.165x	--

About AbClon Inc

KQ:174900 Korea Biotechnology

Market Cap

$296.40 Million

₩437.36 Billion KRW

Market Cap Rank

#14829 Global

#460 in Korea

Share Price

₩21950.00

Change (1 day)

+11.42%

52-Week Range

₩9890.00 - ₩89100.00

All Time High

₩90600.00